Gyre Therapeutics, Inc. GYRE Sales & Marketing
Sales & Marketing at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s sales & marketing.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s sales & marketing?
- Gyre Therapeutics, Inc. (GYRE) reported sales & marketing of $14.14M in Q1 2026.
- How has Gyre Therapeutics, Inc.'s sales & marketing changed year-over-year?
- Gyre Therapeutics, Inc.'s sales & marketing increased by 30.4% year-over-year, from $10.84M to $14.14M.
- What is the long-term trend for Gyre Therapeutics, Inc.'s sales & marketing?
- Over 3 years (2022 to 2025), Gyre Therapeutics, Inc.'s sales & marketing has grown at a 6.3% compound annual growth rate (CAGR), from $54.24M to $65.18M.
- What does sales & marketing mean?
- Costs of selling products and services including sales force compensation, commissions, marketing campaigns, trade shows, and customer acquisition expenses.